CLN3 Monoklonaler Antikörper

CLN3 Monoklonal Antikörper für WB, Indirect ELISA

Wirt / Isotyp

Maus / IgG1

Getestete Reaktivität

human

Anwendung

WB, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

1E10A9

Kat-Nr. : 67957-1-PBS

Synonyme

Batten disease protein, BATTENIN, BTS, CLN3, JNCL, Protein CLN3



Geprüfte Anwendungen

Produktinformation

67957-1-PBS bindet in WB, Indirect ELISA CLN3 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Maus / IgG1
Klonalität Monoklonal
Typ Antikörper
Immunogen CLN3 fusion protein Ag31402
Vollständiger Name ceroid-lipofuscinosis, neuronal 3
Berechnetes Molekulargewicht 438 aa, 48 kDa
Beobachtetes Molekulargewicht50 kDa
GenBank-ZugangsnummerBC002394
Gene symbol CLN3
Gene ID (NCBI) 1201
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-G-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Neuronal ceroid lipofuscinosis (NCL, or Batten disease) refers to a group of lethal pediatric neurodegenerative diseases originating from mutations in one of the thus far identified 13 CLN genes (Ceroid Lipofuscinosis, Neuronal type; CLN1 to CLN14) (PMID: 25051496). CLN3 is a multi-membrane spanning protein that is involved in microtubule-dependent, anterograde transport of late endosomes and lysosomes. The CLN3 gene is located on chromosome 16p12.1and produces three mRNA splicing variants. The 438-amino-acid CLN3 protein has a calculated molecular weight of 48 kDa. It has been reported that CLN3 can be glycosylated and form homodimeric complex (PMID: 10356317; 17286803).